-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
-
Summary
-
Horizon Therapeutics Public Ltd Co quarterly/annual Depreciation history and growth rate from 2010 to 2022.
- Horizon Therapeutics Public Ltd Co Depreciation for the quarter ending June 30, 2023 was $6.7M, a 9.84% increase year-over-year.
- Horizon Therapeutics Public Ltd Co Depreciation for the twelve months ending June 30, 2023 was $24.8M, a 14.5% increase year-over-year.
- Horizon Therapeutics Public Ltd Co annual Depreciation for 2022 was $23.9M, a 36.6% increase from 2021.
- Horizon Therapeutics Public Ltd Co annual Depreciation for 2021 was $17.5M, a 28% decline from 2020.
- Horizon Therapeutics Public Ltd Co annual Depreciation for 2020 was $24.3M, a 261% increase from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)